GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH)

Naim Alkhouri, Eric Lawitz, Mazen Noureddin, Ralph DeFronzo, Gerald I. Shulman

Resultado de la investigación: Article › revisión exhaustiva

65 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'GS-0976 (Firsocostat): an investigational liver-directed acetyl-CoA carboxylase (ACC) inhibitor for the treatment of non-alcoholic steatohepatitis (NASH)'. En conjunto forman una huella única.

Pharmacology, Toxicology and Pharmaceutical Science